FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:1910-1912 June 17, 1999 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Oral, H. Related Article by Pacifico, A. PubMed Citation

The growing recognition of the potentially harmful effects of antiarrhythmic drugs¹ and the subsequent proof from controlled trials that some of these drugs can increase the risk of death in some patients have led to a decline in their use.^2,3 This change in practice has been fueled by the widespread application of nonpharmacologic therapies, such as implantable defibrillators and radio-frequency catheter ablation, which have now become the dominant types of therapy for many patients with ventricular and supraventricular arrhythmias.^4,5

Although these new forms of technology have become first-line therapy for some arrhythmias, there may still be a role for antiarrhythmic . . . [Full Text of this Article]

References

This article has been cited by other articles:

• de Lorgeril, M., Salen, P., Defaye, P., Mabo, P., Paillard, F. (2002). Dietary prevention of sudden cardiac death. Eur Heart J 23: 277-285 [Full Text]  
• Efimov, I. R. (2000). A Shocking Experience : Ionic Modulation of Virtual Electrodes in Defibrillation. Circ. Res. 87: 429-430 [Full Text]  
• Grace, A. A., Camm, A.J. (2000). Voltage-gated calcium-channels and antiarrhythmic drug action. Cardiovasc Res 45: 43-51 [Full Text]  
• Rosen, M. R. (1999). Leaky Dikes and Fibrillating Swine. Circulation 100: 1942-1944 [Full Text]